nodes	percent_of_prediction	percent_of_DWPC	metapath
Temazepam—CYP3A4—bone cancer	0.84	1	CbGaD
Temazepam—Obstructive airways disorder—Methotrexate—bone cancer	0.00434	0.042	CcSEcCtD
Temazepam—Slurred speech—Cisplatin—bone cancer	0.00402	0.0388	CcSEcCtD
Temazepam—Inappropriate antidiuretic hormone secretion—Cisplatin—bone cancer	0.00309	0.0299	CcSEcCtD
Temazepam—Ageusia—Cisplatin—bone cancer	0.00222	0.0214	CcSEcCtD
Temazepam—Dysarthria—Cisplatin—bone cancer	0.0019	0.0184	CcSEcCtD
Temazepam—Hypothermia—Epirubicin—bone cancer	0.00165	0.0159	CcSEcCtD
Temazepam—Body temperature decreased—Epirubicin—bone cancer	0.00165	0.0159	CcSEcCtD
Temazepam—Body temperature decreased—Doxorubicin—bone cancer	0.00152	0.0147	CcSEcCtD
Temazepam—Hypothermia—Doxorubicin—bone cancer	0.00152	0.0147	CcSEcCtD
Temazepam—Amnesia—Cisplatin—bone cancer	0.00139	0.0134	CcSEcCtD
Temazepam—Hyponatraemia—Cisplatin—bone cancer	0.00131	0.0127	CcSEcCtD
Temazepam—Nystagmus—Epirubicin—bone cancer	0.00129	0.0125	CcSEcCtD
Temazepam—Irritability—Cisplatin—bone cancer	0.00125	0.012	CcSEcCtD
Temazepam—Nystagmus—Doxorubicin—bone cancer	0.0012	0.0115	CcSEcCtD
Temazepam—Apnoea—Methotrexate—bone cancer	0.00116	0.0112	CcSEcCtD
Temazepam—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00114	0.0245	CbGpPWpGaD
Temazepam—Ageusia—Epirubicin—bone cancer	0.00114	0.011	CcSEcCtD
Temazepam—Proteinuria—Methotrexate—bone cancer	0.00112	0.0108	CcSEcCtD
Temazepam—Protein urine present—Methotrexate—bone cancer	0.00111	0.0107	CcSEcCtD
Temazepam—Abdominal discomfort—Cisplatin—bone cancer	0.00108	0.0104	CcSEcCtD
Temazepam—Ageusia—Doxorubicin—bone cancer	0.00105	0.0102	CcSEcCtD
Temazepam—Dysarthria—Methotrexate—bone cancer	0.00104	0.0101	CcSEcCtD
Temazepam—Dysarthria—Epirubicin—bone cancer	0.000976	0.00943	CcSEcCtD
Temazepam—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000968	0.0207	CbGpPWpGaD
Temazepam—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.000961	0.0206	CbGpPWpGaD
Temazepam—Depressed level of consciousness—Methotrexate—bone cancer	0.000952	0.0092	CcSEcCtD
Temazepam—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000926	0.0198	CbGpPWpGaD
Temazepam—Abnormal dreams—Epirubicin—bone cancer	0.000912	0.00881	CcSEcCtD
Temazepam—Dysarthria—Doxorubicin—bone cancer	0.000903	0.00872	CcSEcCtD
Temazepam—Coma—Methotrexate—bone cancer	0.000901	0.0087	CcSEcCtD
Temazepam—Visual impairment—Cisplatin—bone cancer	0.00087	0.0084	CcSEcCtD
Temazepam—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000864	0.0185	CbGpPWpGaD
Temazepam—Ketazolam—CYP3A4—bone cancer	0.000849	0.0887	CrCbGaD
Temazepam—Cramps of lower extremities—Epirubicin—bone cancer	0.000848	0.00819	CcSEcCtD
Temazepam—Abnormal dreams—Doxorubicin—bone cancer	0.000844	0.00815	CcSEcCtD
Temazepam—Coma—Epirubicin—bone cancer	0.000843	0.00815	CcSEcCtD
Temazepam—GABRQ—Orphan transporters—TUBB4B—bone cancer	0.000823	0.0176	CbGpPWpGaD
Temazepam—GABRR2—Mecp2 and Associated Rett Syndrome—EZH2—bone cancer	0.000799	0.0171	CbGpPWpGaD
Temazepam—Alopecia—Cisplatin—bone cancer	0.000797	0.0077	CcSEcCtD
Temazepam—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	0.000794	0.017	CbGpPWpGaD
Temazepam—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000788	0.0169	CbGpPWpGaD
Temazepam—Cramps of lower extremities—Doxorubicin—bone cancer	0.000784	0.00758	CcSEcCtD
Temazepam—Coma—Doxorubicin—bone cancer	0.00078	0.00754	CcSEcCtD
Temazepam—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.00077	0.00744	CcSEcCtD
Temazepam—Visual disturbance—Methotrexate—bone cancer	0.000755	0.0073	CcSEcCtD
Temazepam—Muscle spasms—Cisplatin—bone cancer	0.000755	0.0073	CcSEcCtD
Temazepam—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000753	0.0161	CbGpPWpGaD
Temazepam—Vision blurred—Cisplatin—bone cancer	0.00074	0.00715	CcSEcCtD
Temazepam—Tremor—Cisplatin—bone cancer	0.000736	0.00711	CcSEcCtD
Temazepam—Lethargy—Methotrexate—bone cancer	0.00073	0.00706	CcSEcCtD
Temazepam—Osteoarthritis—Methotrexate—bone cancer	0.000716	0.00692	CcSEcCtD
Temazepam—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000713	0.00688	CcSEcCtD
Temazepam—GABRQ—Orphan transporters—TUBB2A—bone cancer	0.00071	0.0152	CbGpPWpGaD
Temazepam—Chlordiazepoxide—CYP3A4—bone cancer	0.000709	0.0741	CrCbGaD
Temazepam—Lethargy—Epirubicin—bone cancer	0.000684	0.0066	CcSEcCtD
Temazepam—Irritability—Methotrexate—bone cancer	0.000683	0.0066	CcSEcCtD
Temazepam—Convulsion—Cisplatin—bone cancer	0.000681	0.00658	CcSEcCtD
Temazepam—GABRG3—Orphan transporters—TUBB4B—bone cancer	0.000677	0.0145	CbGpPWpGaD
Temazepam—Ataxia—Methotrexate—bone cancer	0.000673	0.0065	CcSEcCtD
Temazepam—Hyponatraemia—Epirubicin—bone cancer	0.000673	0.0065	CcSEcCtD
Temazepam—Osteoarthritis—Epirubicin—bone cancer	0.00067	0.00647	CcSEcCtD
Temazepam—Diplopia—Epirubicin—bone cancer	0.00067	0.00647	CcSEcCtD
Temazepam—GABRB1—Orphan transporters—TUBB4B—bone cancer	0.000667	0.0143	CbGpPWpGaD
Temazepam—Anxiety—Cisplatin—bone cancer	0.000666	0.00644	CcSEcCtD
Temazepam—Clorazepate—CYP3A4—bone cancer	0.000663	0.0693	CrCbGaD
Temazepam—Lethargy—Doxorubicin—bone cancer	0.000632	0.00611	CcSEcCtD
Temazepam—GABRA6—Orphan transporters—TUBB4B—bone cancer	0.000631	0.0135	CbGpPWpGaD
Temazepam—Ataxia—Epirubicin—bone cancer	0.00063	0.00609	CcSEcCtD
Temazepam—Flurbiprofen—PTGS2—bone cancer	0.000629	0.0657	CrCbGaD
Temazepam—Thrombocytopenia—Cisplatin—bone cancer	0.000628	0.00606	CcSEcCtD
Temazepam—Tachycardia—Cisplatin—bone cancer	0.000626	0.00604	CcSEcCtD
Temazepam—GABRA4—Orphan transporters—TUBB4B—bone cancer	0.000623	0.0133	CbGpPWpGaD
Temazepam—Hyponatraemia—Doxorubicin—bone cancer	0.000622	0.00601	CcSEcCtD
Temazepam—Diplopia—Doxorubicin—bone cancer	0.00062	0.00599	CcSEcCtD
Temazepam—Osteoarthritis—Doxorubicin—bone cancer	0.00062	0.00599	CcSEcCtD
Temazepam—Hyperhidrosis—Cisplatin—bone cancer	0.00062	0.00599	CcSEcCtD
Temazepam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000618	0.0132	CbGpPWpGaD
Temazepam—Anorexia—Cisplatin—bone cancer	0.000611	0.0059	CcSEcCtD
Temazepam—Clobazam—CYP3A4—bone cancer	0.0006	0.0627	CrCbGaD
Temazepam—Alprazolam—CYP3A4—bone cancer	0.0006	0.0627	CrCbGaD
Temazepam—Hypotension—Cisplatin—bone cancer	0.000599	0.00579	CcSEcCtD
Temazepam—Abdominal discomfort—Methotrexate—bone cancer	0.000593	0.00573	CcSEcCtD
Temazepam—GABRG3—Orphan transporters—TUBB2A—bone cancer	0.000585	0.0125	CbGpPWpGaD
Temazepam—Ataxia—Doxorubicin—bone cancer	0.000583	0.00563	CcSEcCtD
Temazepam—Quazepam—CYP3A4—bone cancer	0.000582	0.0608	CrCbGaD
Temazepam—GABRB1—Orphan transporters—TUBB2A—bone cancer	0.000576	0.0123	CbGpPWpGaD
Temazepam—Dyspnoea—Cisplatin—bone cancer	0.000572	0.00552	CcSEcCtD
Temazepam—GABRB2—Orphan transporters—TUBB4B—bone cancer	0.00057	0.0122	CbGpPWpGaD
Temazepam—Erectile dysfunction—Methotrexate—bone cancer	0.00057	0.0055	CcSEcCtD
Temazepam—Decreased appetite—Cisplatin—bone cancer	0.000557	0.00538	CcSEcCtD
Temazepam—GABRA5—Orphan transporters—TUBB4B—bone cancer	0.000554	0.0119	CbGpPWpGaD
Temazepam—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000552	0.0118	CbGpPWpGaD
Temazepam—Drowsiness—Methotrexate—bone cancer	0.000552	0.00533	CcSEcCtD
Temazepam—Depression—Methotrexate—bone cancer	0.00055	0.00531	CcSEcCtD
Temazepam—Flunitrazepam—CYP3A4—bone cancer	0.00055	0.0574	CrCbGaD
Temazepam—GABRA6—Orphan transporters—TUBB2A—bone cancer	0.000545	0.0117	CbGpPWpGaD
Temazepam—GABRA3—Orphan transporters—TUBB4B—bone cancer	0.000544	0.0116	CbGpPWpGaD
Temazepam—GABRA4—Orphan transporters—TUBB2A—bone cancer	0.000538	0.0115	CbGpPWpGaD
Temazepam—GABRA2—Orphan transporters—TUBB4B—bone cancer	0.000535	0.0114	CbGpPWpGaD
Temazepam—GABRB3—Orphan transporters—TUBB4B—bone cancer	0.000531	0.0114	CbGpPWpGaD
Temazepam—Feeling abnormal—Cisplatin—bone cancer	0.000528	0.0051	CcSEcCtD
Temazepam—GABRG2—Orphan transporters—TUBB4B—bone cancer	0.000522	0.0112	CbGpPWpGaD
Temazepam—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00052	0.0111	CbGpPWpGaD
Temazepam—Drowsiness—Epirubicin—bone cancer	0.000516	0.00499	CcSEcCtD
Temazepam—Agranulocytosis—Methotrexate—bone cancer	0.000515	0.00497	CcSEcCtD
Temazepam—Estazolam—CYP3A4—bone cancer	0.000514	0.0537	CrCbGaD
Temazepam—Jaundice—Epirubicin—bone cancer	0.000503	0.00486	CcSEcCtD
Temazepam—Nitrazepam—CYP3A4—bone cancer	0.000496	0.0518	CrCbGaD
Temazepam—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000492	0.0105	CbGpPWpGaD
Temazepam—GABRB2—Orphan transporters—TUBB2A—bone cancer	0.000492	0.0105	CbGpPWpGaD
Temazepam—Adinazolam—CYP3A4—bone cancer	0.000489	0.0511	CrCbGaD
Temazepam—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000489	0.0105	CbGpPWpGaD
Temazepam—Agranulocytosis—Epirubicin—bone cancer	0.000482	0.00465	CcSEcCtD
Temazepam—GABRA5—Orphan transporters—TUBB2A—bone cancer	0.000478	0.0102	CbGpPWpGaD
Temazepam—Drowsiness—Doxorubicin—bone cancer	0.000478	0.00461	CcSEcCtD
Temazepam—Visual impairment—Methotrexate—bone cancer	0.000477	0.00461	CcSEcCtD
Temazepam—Prazepam—CYP3A4—bone cancer	0.000473	0.0494	CrCbGaD
Temazepam—Hypersensitivity—Cisplatin—bone cancer	0.000472	0.00456	CcSEcCtD
Temazepam—GABRA3—Orphan transporters—TUBB2A—bone cancer	0.00047	0.0101	CbGpPWpGaD
Temazepam—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000467	0.01	CbGpPWpGaD
Temazepam—Jaundice—Doxorubicin—bone cancer	0.000466	0.0045	CcSEcCtD
Temazepam—GABRA2—Orphan transporters—TUBB2A—bone cancer	0.000461	0.00988	CbGpPWpGaD
Temazepam—Asthenia—Cisplatin—bone cancer	0.00046	0.00444	CcSEcCtD
Temazepam—GABRB3—Orphan transporters—TUBB2A—bone cancer	0.000458	0.00981	CbGpPWpGaD
Temazepam—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.000456	0.00976	CbGpPWpGaD
Temazepam—GABRG2—Orphan transporters—TUBB2A—bone cancer	0.00045	0.00964	CbGpPWpGaD
Temazepam—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000449	0.00962	CbGpPWpGaD
Temazepam—Visual impairment—Epirubicin—bone cancer	0.000447	0.00431	CcSEcCtD
Temazepam—Agranulocytosis—Doxorubicin—bone cancer	0.000446	0.00431	CcSEcCtD
Temazepam—Flurazepam—CYP3A4—bone cancer	0.000441	0.0461	CrCbGaD
Temazepam—Triazolam—CYP3A4—bone cancer	0.000441	0.046	CrCbGaD
Temazepam—Diarrhoea—Cisplatin—bone cancer	0.000439	0.00424	CcSEcCtD
Temazepam—Alopecia—Methotrexate—bone cancer	0.000438	0.00423	CcSEcCtD
Temazepam—Oxazepam—CYP3A4—bone cancer	0.000427	0.0446	CrCbGaD
Temazepam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000426	0.00912	CbGpPWpGaD
Temazepam—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000417	0.00893	CbGpPWpGaD
Temazepam—Back pain—Methotrexate—bone cancer	0.000417	0.00403	CcSEcCtD
Temazepam—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000417	0.00892	CbGpPWpGaD
Temazepam—Visual impairment—Doxorubicin—bone cancer	0.000413	0.00399	CcSEcCtD
Temazepam—Alopecia—Epirubicin—bone cancer	0.000409	0.00396	CcSEcCtD
Temazepam—Midazolam—CYP3A4—bone cancer	0.000409	0.0427	CrCbGaD
Temazepam—Vomiting—Cisplatin—bone cancer	0.000408	0.00394	CcSEcCtD
Temazepam—Vision blurred—Methotrexate—bone cancer	0.000406	0.00392	CcSEcCtD
Temazepam—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000401	0.00859	CbGpPWpGaD
Temazepam—Tension—Epirubicin—bone cancer	0.000396	0.00382	CcSEcCtD
Temazepam—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000393	0.00842	CbGpPWpGaD
Temazepam—Nervousness—Epirubicin—bone cancer	0.000392	0.00379	CcSEcCtD
Temazepam—Back pain—Epirubicin—bone cancer	0.00039	0.00377	CcSEcCtD
Temazepam—Muscle spasms—Epirubicin—bone cancer	0.000388	0.00375	CcSEcCtD
Temazepam—Vertigo—Methotrexate—bone cancer	0.000387	0.00374	CcSEcCtD
Temazepam—Nausea—Cisplatin—bone cancer	0.000381	0.00368	CcSEcCtD
Temazepam—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.00038	0.00814	CbGpPWpGaD
Temazepam—Vision blurred—Epirubicin—bone cancer	0.00038	0.00367	CcSEcCtD
Temazepam—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000379	0.00811	CbGpPWpGaD
Temazepam—Alopecia—Doxorubicin—bone cancer	0.000379	0.00366	CcSEcCtD
Temazepam—Convulsion—Methotrexate—bone cancer	0.000373	0.00361	CcSEcCtD
Temazepam—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000372	0.00796	CbGpPWpGaD
Temazepam—Agitation—Epirubicin—bone cancer	0.000371	0.00358	CcSEcCtD
Temazepam—Tension—Doxorubicin—bone cancer	0.000366	0.00354	CcSEcCtD
Temazepam—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000366	0.00783	CbGpPWpGaD
Temazepam—Nervousness—Doxorubicin—bone cancer	0.000363	0.0035	CcSEcCtD
Temazepam—Vertigo—Epirubicin—bone cancer	0.000362	0.0035	CcSEcCtD
Temazepam—Syncope—Epirubicin—bone cancer	0.000362	0.00349	CcSEcCtD
Temazepam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000361	0.00773	CbGpPWpGaD
Temazepam—Back pain—Doxorubicin—bone cancer	0.000361	0.00349	CcSEcCtD
Temazepam—Muscle spasms—Doxorubicin—bone cancer	0.000359	0.00347	CcSEcCtD
Temazepam—Palpitations—Epirubicin—bone cancer	0.000356	0.00344	CcSEcCtD
Temazepam—Confusional state—Methotrexate—bone cancer	0.000355	0.00343	CcSEcCtD
Temazepam—Loss of consciousness—Epirubicin—bone cancer	0.000355	0.00343	CcSEcCtD
Temazepam—Vision blurred—Doxorubicin—bone cancer	0.000352	0.0034	CcSEcCtD
Temazepam—Diazepam—CYP3A4—bone cancer	0.00035	0.0366	CrCbGaD
Temazepam—Convulsion—Epirubicin—bone cancer	0.00035	0.00338	CcSEcCtD
Temazepam—Clozapine—CYP3A4—bone cancer	0.000346	0.0362	CrCbGaD
Temazepam—Thrombocytopenia—Methotrexate—bone cancer	0.000344	0.00333	CcSEcCtD
Temazepam—Agitation—Doxorubicin—bone cancer	0.000343	0.00331	CcSEcCtD
Temazepam—Anxiety—Epirubicin—bone cancer	0.000342	0.00331	CcSEcCtD
Temazepam—Hyperhidrosis—Methotrexate—bone cancer	0.00034	0.00329	CcSEcCtD
Temazepam—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000339	0.00726	CbGpPWpGaD
Temazepam—Dry mouth—Epirubicin—bone cancer	0.000336	0.00324	CcSEcCtD
Temazepam—Vertigo—Doxorubicin—bone cancer	0.000335	0.00324	CcSEcCtD
Temazepam—Anorexia—Methotrexate—bone cancer	0.000335	0.00324	CcSEcCtD
Temazepam—Syncope—Doxorubicin—bone cancer	0.000335	0.00323	CcSEcCtD
Temazepam—Confusional state—Epirubicin—bone cancer	0.000332	0.00321	CcSEcCtD
Temazepam—Palpitations—Doxorubicin—bone cancer	0.00033	0.00319	CcSEcCtD
Temazepam—Hypotension—Methotrexate—bone cancer	0.000329	0.00318	CcSEcCtD
Temazepam—Loss of consciousness—Doxorubicin—bone cancer	0.000328	0.00317	CcSEcCtD
Temazepam—Shock—Epirubicin—bone cancer	0.000324	0.00313	CcSEcCtD
Temazepam—Convulsion—Doxorubicin—bone cancer	0.000323	0.00312	CcSEcCtD
Temazepam—Thrombocytopenia—Epirubicin—bone cancer	0.000322	0.00311	CcSEcCtD
Temazepam—Tachycardia—Epirubicin—bone cancer	0.000321	0.0031	CcSEcCtD
Temazepam—Hyperhidrosis—Epirubicin—bone cancer	0.000318	0.00307	CcSEcCtD
Temazepam—Anxiety—Doxorubicin—bone cancer	0.000317	0.00306	CcSEcCtD
Temazepam—Anorexia—Epirubicin—bone cancer	0.000314	0.00303	CcSEcCtD
Temazepam—Dyspnoea—Methotrexate—bone cancer	0.000314	0.00303	CcSEcCtD
Temazepam—Somnolence—Methotrexate—bone cancer	0.000313	0.00302	CcSEcCtD
Temazepam—Dry mouth—Doxorubicin—bone cancer	0.000311	0.003	CcSEcCtD
Temazepam—Hypotension—Epirubicin—bone cancer	0.000308	0.00297	CcSEcCtD
Temazepam—Confusional state—Doxorubicin—bone cancer	0.000307	0.00297	CcSEcCtD
Temazepam—Decreased appetite—Methotrexate—bone cancer	0.000306	0.00295	CcSEcCtD
Temazepam—Fatigue—Methotrexate—bone cancer	0.000303	0.00293	CcSEcCtD
Temazepam—Shock—Doxorubicin—bone cancer	0.0003	0.0029	CcSEcCtD
Temazepam—Thrombocytopenia—Doxorubicin—bone cancer	0.000298	0.00288	CcSEcCtD
Temazepam—Tachycardia—Doxorubicin—bone cancer	0.000297	0.00287	CcSEcCtD
Temazepam—Hyperhidrosis—Doxorubicin—bone cancer	0.000294	0.00285	CcSEcCtD
Temazepam—Dyspnoea—Epirubicin—bone cancer	0.000294	0.00284	CcSEcCtD
Temazepam—Somnolence—Epirubicin—bone cancer	0.000293	0.00283	CcSEcCtD
Temazepam—Anorexia—Doxorubicin—bone cancer	0.00029	0.00281	CcSEcCtD
Temazepam—Feeling abnormal—Methotrexate—bone cancer	0.00029	0.0028	CcSEcCtD
Temazepam—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000286	0.00613	CbGpPWpGaD
Temazepam—Decreased appetite—Epirubicin—bone cancer	0.000286	0.00276	CcSEcCtD
Temazepam—Hypotension—Doxorubicin—bone cancer	0.000285	0.00275	CcSEcCtD
Temazepam—Fatigue—Epirubicin—bone cancer	0.000284	0.00274	CcSEcCtD
Temazepam—Constipation—Epirubicin—bone cancer	0.000282	0.00272	CcSEcCtD
Temazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000281	0.00601	CbGpPWpGaD
Temazepam—Dyspnoea—Doxorubicin—bone cancer	0.000272	0.00262	CcSEcCtD
Temazepam—Feeling abnormal—Epirubicin—bone cancer	0.000271	0.00262	CcSEcCtD
Temazepam—Somnolence—Doxorubicin—bone cancer	0.000271	0.00262	CcSEcCtD
Temazepam—Decreased appetite—Doxorubicin—bone cancer	0.000265	0.00256	CcSEcCtD
Temazepam—Fatigue—Doxorubicin—bone cancer	0.000263	0.00254	CcSEcCtD
Temazepam—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000261	0.00559	CbGpPWpGaD
Temazepam—Constipation—Doxorubicin—bone cancer	0.000261	0.00252	CcSEcCtD
Temazepam—Hypersensitivity—Methotrexate—bone cancer	0.000259	0.0025	CcSEcCtD
Temazepam—Asthenia—Methotrexate—bone cancer	0.000252	0.00244	CcSEcCtD
Temazepam—Feeling abnormal—Doxorubicin—bone cancer	0.000251	0.00243	CcSEcCtD
Temazepam—Pruritus—Methotrexate—bone cancer	0.000249	0.0024	CcSEcCtD
Temazepam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000249	0.00533	CbGpPWpGaD
Temazepam—GABRB3—BDNF signaling pathway—EIF2S1—bone cancer	0.000246	0.00528	CbGpPWpGaD
Temazepam—Hypersensitivity—Epirubicin—bone cancer	0.000243	0.00234	CcSEcCtD
Temazepam—Diarrhoea—Methotrexate—bone cancer	0.000241	0.00233	CcSEcCtD
Temazepam—Asthenia—Epirubicin—bone cancer	0.000236	0.00228	CcSEcCtD
Temazepam—Pruritus—Epirubicin—bone cancer	0.000233	0.00225	CcSEcCtD
Temazepam—Dizziness—Methotrexate—bone cancer	0.000233	0.00225	CcSEcCtD
Temazepam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000229	0.00491	CbGpPWpGaD
Temazepam—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000226	0.00484	CbGpPWpGaD
Temazepam—Diarrhoea—Epirubicin—bone cancer	0.000225	0.00218	CcSEcCtD
Temazepam—Hypersensitivity—Doxorubicin—bone cancer	0.000224	0.00217	CcSEcCtD
Temazepam—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000224	0.00479	CbGpPWpGaD
Temazepam—Vomiting—Methotrexate—bone cancer	0.000224	0.00216	CcSEcCtD
Temazepam—Headache—Methotrexate—bone cancer	0.00022	0.00213	CcSEcCtD
Temazepam—Asthenia—Doxorubicin—bone cancer	0.000219	0.00211	CcSEcCtD
Temazepam—Dizziness—Epirubicin—bone cancer	0.000218	0.0021	CcSEcCtD
Temazepam—Pruritus—Doxorubicin—bone cancer	0.000216	0.00208	CcSEcCtD
Temazepam—GABRR1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000211	0.00451	CbGpPWpGaD
Temazepam—Vomiting—Epirubicin—bone cancer	0.000209	0.00202	CcSEcCtD
Temazepam—Nausea—Methotrexate—bone cancer	0.000209	0.00202	CcSEcCtD
Temazepam—Diarrhoea—Doxorubicin—bone cancer	0.000208	0.00201	CcSEcCtD
Temazepam—Headache—Epirubicin—bone cancer	0.000206	0.00199	CcSEcCtD
Temazepam—Dizziness—Doxorubicin—bone cancer	0.000201	0.00195	CcSEcCtD
Temazepam—GABRQ—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000201	0.0043	CbGpPWpGaD
Temazepam—GABRR2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000201	0.0043	CbGpPWpGaD
Temazepam—Nausea—Epirubicin—bone cancer	0.000196	0.00189	CcSEcCtD
Temazepam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000194	0.00415	CbGpPWpGaD
Temazepam—Vomiting—Doxorubicin—bone cancer	0.000194	0.00187	CcSEcCtD
Temazepam—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000192	0.0041	CbGpPWpGaD
Temazepam—Headache—Doxorubicin—bone cancer	0.000191	0.00184	CcSEcCtD
Temazepam—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000186	0.00398	CbGpPWpGaD
Temazepam—GABRR1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000182	0.00389	CbGpPWpGaD
Temazepam—Nausea—Doxorubicin—bone cancer	0.000181	0.00175	CcSEcCtD
Temazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000178	0.0038	CbGpPWpGaD
Temazepam—GABRR2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000173	0.00371	CbGpPWpGaD
Temazepam—GABRQ—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000173	0.00371	CbGpPWpGaD
Temazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000173	0.00371	CbGpPWpGaD
Temazepam—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000171	0.00366	CbGpPWpGaD
Temazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000169	0.00363	CbGpPWpGaD
Temazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000169	0.00363	CbGpPWpGaD
Temazepam—GABRG3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000165	0.00354	CbGpPWpGaD
Temazepam—GABRB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000163	0.00349	CbGpPWpGaD
Temazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000158	0.00338	CbGpPWpGaD
Temazepam—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000157	0.00337	CbGpPWpGaD
Temazepam—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000156	0.00334	CbGpPWpGaD
Temazepam—GABRA6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000154	0.0033	CbGpPWpGaD
Temazepam—GABRA4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000152	0.00326	CbGpPWpGaD
Temazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000149	0.00319	CbGpPWpGaD
Temazepam—GABRG3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000143	0.00306	CbGpPWpGaD
Temazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000142	0.00304	CbGpPWpGaD
Temazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000142	0.00304	CbGpPWpGaD
Temazepam—GABRB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000141	0.00301	CbGpPWpGaD
Temazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00014	0.00301	CbGpPWpGaD
Temazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00014	0.00299	CbGpPWpGaD
Temazepam—GABRB2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000139	0.00298	CbGpPWpGaD
Temazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000137	0.00294	CbGpPWpGaD
Temazepam—GABRA5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000135	0.00289	CbGpPWpGaD
Temazepam—GABRR1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000134	0.00286	CbGpPWpGaD
Temazepam—GABRA6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000133	0.00285	CbGpPWpGaD
Temazepam—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000133	0.00284	CbGpPWpGaD
Temazepam—GABRA4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000131	0.00281	CbGpPWpGaD
Temazepam—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000131	0.00279	CbGpPWpGaD
Temazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00013	0.00278	CbGpPWpGaD
Temazepam—GABRB3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00013	0.00278	CbGpPWpGaD
Temazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000128	0.00275	CbGpPWpGaD
Temazepam—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000128	0.00274	CbGpPWpGaD
Temazepam—GABRQ—Transmission across Chemical Synapses—BRAF—bone cancer	0.000127	0.00273	CbGpPWpGaD
Temazepam—GABRR2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000127	0.00273	CbGpPWpGaD
Temazepam—GABRG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000127	0.00273	CbGpPWpGaD
Temazepam—GABRB2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00012	0.00257	CbGpPWpGaD
Temazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000117	0.00251	CbGpPWpGaD
Temazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000117	0.0025	CbGpPWpGaD
Temazepam—GABRA5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000117	0.0025	CbGpPWpGaD
Temazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000115	0.00246	CbGpPWpGaD
Temazepam—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000115	0.00245	CbGpPWpGaD
Temazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000114	0.00244	CbGpPWpGaD
Temazepam—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000113	0.00241	CbGpPWpGaD
Temazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000112	0.0024	CbGpPWpGaD
Temazepam—GABRB3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000112	0.0024	CbGpPWpGaD
Temazepam—GABRR1—Transmission across Chemical Synapses—MDM2—bone cancer	0.000112	0.00239	CbGpPWpGaD
Temazepam—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000111	0.00238	CbGpPWpGaD
Temazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00011	0.00236	CbGpPWpGaD
Temazepam—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00011	0.00235	CbGpPWpGaD
Temazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000109	0.00234	CbGpPWpGaD
Temazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000109	0.00233	CbGpPWpGaD
Temazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000108	0.0023	CbGpPWpGaD
Temazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000107	0.0023	CbGpPWpGaD
Temazepam—GABRR2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000107	0.00228	CbGpPWpGaD
Temazepam—GABRQ—Transmission across Chemical Synapses—MDM2—bone cancer	0.000107	0.00228	CbGpPWpGaD
Temazepam—GABRG3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000105	0.00224	CbGpPWpGaD
Temazepam—GABRB1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000103	0.00221	CbGpPWpGaD
Temazepam—GABRR1—Neuronal System—BRAF—bone cancer	0.000102	0.00219	CbGpPWpGaD
Temazepam—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	9.95e-05	0.00213	CbGpPWpGaD
Temazepam—CYP2B6—Biological oxidations—CYP3A4—bone cancer	9.87e-05	0.00211	CbGpPWpGaD
Temazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	9.84e-05	0.00211	CbGpPWpGaD
Temazepam—GABRA6—Transmission across Chemical Synapses—BRAF—bone cancer	9.78e-05	0.00209	CbGpPWpGaD
Temazepam—GABRR2—Neuronal System—BRAF—bone cancer	9.76e-05	0.00209	CbGpPWpGaD
Temazepam—GABRQ—Neuronal System—BRAF—bone cancer	9.76e-05	0.00209	CbGpPWpGaD
Temazepam—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	9.74e-05	0.00208	CbGpPWpGaD
Temazepam—GABRA4—Transmission across Chemical Synapses—BRAF—bone cancer	9.65e-05	0.00207	CbGpPWpGaD
Temazepam—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.61e-05	0.00206	CbGpPWpGaD
Temazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	9.56e-05	0.00205	CbGpPWpGaD
Temazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	9.39e-05	0.00201	CbGpPWpGaD
Temazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	9.39e-05	0.00201	CbGpPWpGaD
Temazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	9.22e-05	0.00197	CbGpPWpGaD
Temazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	9.16e-05	0.00196	CbGpPWpGaD
Temazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	9e-05	0.00193	CbGpPWpGaD
Temazepam—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	8.88e-05	0.0019	CbGpPWpGaD
Temazepam—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	8.83e-05	0.00189	CbGpPWpGaD
Temazepam—GABRG3—Transmission across Chemical Synapses—MDM2—bone cancer	8.79e-05	0.00188	CbGpPWpGaD
Temazepam—GABRB1—Transmission across Chemical Synapses—MDM2—bone cancer	8.66e-05	0.00185	CbGpPWpGaD
Temazepam—GABRA5—Transmission across Chemical Synapses—BRAF—bone cancer	8.58e-05	0.00184	CbGpPWpGaD
Temazepam—GABRR1—Neuronal System—MDM2—bone cancer	8.57e-05	0.00183	CbGpPWpGaD
Temazepam—CYP2B6—Biological oxidations—GSTP1—bone cancer	8.44e-05	0.00181	CbGpPWpGaD
Temazepam—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	8.42e-05	0.0018	CbGpPWpGaD
Temazepam—CYP2C8—Biological oxidations—CYP3A4—bone cancer	8.36e-05	0.00179	CbGpPWpGaD
Temazepam—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	8.33e-05	0.00178	CbGpPWpGaD
Temazepam—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	8.28e-05	0.00177	CbGpPWpGaD
Temazepam—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	8.24e-05	0.00176	CbGpPWpGaD
Temazepam—GABRB3—Transmission across Chemical Synapses—BRAF—bone cancer	8.22e-05	0.00176	CbGpPWpGaD
Temazepam—GABRA6—Transmission across Chemical Synapses—MDM2—bone cancer	8.19e-05	0.00175	CbGpPWpGaD
Temazepam—GABRR2—Neuronal System—MDM2—bone cancer	8.18e-05	0.00175	CbGpPWpGaD
Temazepam—GABRQ—Neuronal System—MDM2—bone cancer	8.18e-05	0.00175	CbGpPWpGaD
Temazepam—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	8.1e-05	0.00173	CbGpPWpGaD
Temazepam—GABRA4—Transmission across Chemical Synapses—MDM2—bone cancer	8.09e-05	0.00173	CbGpPWpGaD
Temazepam—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	8.07e-05	0.00173	CbGpPWpGaD
Temazepam—GABRG3—Neuronal System—BRAF—bone cancer	8.04e-05	0.00172	CbGpPWpGaD
Temazepam—GABRB1—Neuronal System—BRAF—bone cancer	7.92e-05	0.00169	CbGpPWpGaD
Temazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	7.87e-05	0.00168	CbGpPWpGaD
Temazepam—GABRB3—BDNF signaling pathway—JUN—bone cancer	7.79e-05	0.00167	CbGpPWpGaD
Temazepam—GABRA6—Neuronal System—BRAF—bone cancer	7.49e-05	0.0016	CbGpPWpGaD
Temazepam—CYP2C19—Biological oxidations—CYP3A4—bone cancer	7.46e-05	0.0016	CbGpPWpGaD
Temazepam—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	7.4e-05	0.00158	CbGpPWpGaD
Temazepam—GABRA4—Neuronal System—BRAF—bone cancer	7.4e-05	0.00158	CbGpPWpGaD
Temazepam—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	7.36e-05	0.00157	CbGpPWpGaD
Temazepam—GABRA5—Transmission across Chemical Synapses—MDM2—bone cancer	7.19e-05	0.00154	CbGpPWpGaD
Temazepam—CYP2C8—Biological oxidations—GSTP1—bone cancer	7.15e-05	0.00153	CbGpPWpGaD
Temazepam—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	7.06e-05	0.00151	CbGpPWpGaD
Temazepam—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	7.06e-05	0.00151	CbGpPWpGaD
Temazepam—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	7.05e-05	0.00151	CbGpPWpGaD
Temazepam—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	6.93e-05	0.00148	CbGpPWpGaD
Temazepam—GABRB3—Transmission across Chemical Synapses—MDM2—bone cancer	6.89e-05	0.00147	CbGpPWpGaD
Temazepam—CYP2C9—Biological oxidations—CYP3A4—bone cancer	6.8e-05	0.00146	CbGpPWpGaD
Temazepam—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	6.77e-05	0.00145	CbGpPWpGaD
Temazepam—GABRB2—Neuronal System—BRAF—bone cancer	6.76e-05	0.00145	CbGpPWpGaD
Temazepam—GABRG3—Neuronal System—MDM2—bone cancer	6.73e-05	0.00144	CbGpPWpGaD
Temazepam—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	6.71e-05	0.00144	CbGpPWpGaD
Temazepam—GABRB1—Neuronal System—MDM2—bone cancer	6.63e-05	0.00142	CbGpPWpGaD
Temazepam—GABRA5—Neuronal System—BRAF—bone cancer	6.57e-05	0.00141	CbGpPWpGaD
Temazepam—GABRA3—Neuronal System—BRAF—bone cancer	6.45e-05	0.00138	CbGpPWpGaD
Temazepam—CYP2C19—Biological oxidations—GSTP1—bone cancer	6.38e-05	0.00137	CbGpPWpGaD
Temazepam—GABRA2—Neuronal System—BRAF—bone cancer	6.34e-05	0.00136	CbGpPWpGaD
Temazepam—GABRB3—Neuronal System—BRAF—bone cancer	6.3e-05	0.00135	CbGpPWpGaD
Temazepam—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	6.29e-05	0.00135	CbGpPWpGaD
Temazepam—GABRA6—Neuronal System—MDM2—bone cancer	6.28e-05	0.00134	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	6.27e-05	0.00134	CbGpPWpGaD
Temazepam—GABRA4—Neuronal System—MDM2—bone cancer	6.2e-05	0.00133	CbGpPWpGaD
Temazepam—GABRG2—Neuronal System—BRAF—bone cancer	6.19e-05	0.00132	CbGpPWpGaD
Temazepam—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.92e-05	0.00127	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—NDUFA12—bone cancer	5.92e-05	0.00127	CbGpPWpGaD
Temazepam—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	5.91e-05	0.00127	CbGpPWpGaD
Temazepam—CYP2C9—Biological oxidations—GSTP1—bone cancer	5.82e-05	0.00125	CbGpPWpGaD
Temazepam—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	5.74e-05	0.00123	CbGpPWpGaD
Temazepam—GABRB2—Neuronal System—MDM2—bone cancer	5.67e-05	0.00121	CbGpPWpGaD
Temazepam—GABRA5—Neuronal System—MDM2—bone cancer	5.51e-05	0.00118	CbGpPWpGaD
Temazepam—GABRA1—Neuronal System—BRAF—bone cancer	5.41e-05	0.00116	CbGpPWpGaD
Temazepam—GABRA3—Neuronal System—MDM2—bone cancer	5.41e-05	0.00116	CbGpPWpGaD
Temazepam—GABRA2—Neuronal System—MDM2—bone cancer	5.31e-05	0.00114	CbGpPWpGaD
Temazepam—GABRB3—Neuronal System—MDM2—bone cancer	5.28e-05	0.00113	CbGpPWpGaD
Temazepam—GABRG2—Neuronal System—MDM2—bone cancer	5.18e-05	0.00111	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—NDUFA12—bone cancer	5.01e-05	0.00107	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—NT5C3A—bone cancer	4.9e-05	0.00105	CbGpPWpGaD
Temazepam—GABRA1—Neuronal System—MDM2—bone cancer	4.53e-05	0.00097	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—NDUFA12—bone cancer	4.47e-05	0.000957	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—NT5C3A—bone cancer	4.15e-05	0.000888	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—NDUFA12—bone cancer	4.08e-05	0.000873	CbGpPWpGaD
Temazepam—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.84e-05	0.000821	CbGpPWpGaD
Temazepam—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.78e-05	0.00081	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—NT5C3A—bone cancer	3.71e-05	0.000793	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—NT5C3A—bone cancer	3.38e-05	0.000723	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—NDUFA12—bone cancer	2.69e-05	0.000576	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—NT5C3A—bone cancer	2.23e-05	0.000477	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—ENO2—bone cancer	2.15e-05	0.00046	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—DHFR—bone cancer	1.99e-05	0.000426	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—GNA11—bone cancer	1.86e-05	0.000399	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—ENO2—bone cancer	1.82e-05	0.000389	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—CYP3A4—bone cancer	1.69e-05	0.000361	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—DHFR—bone cancer	1.69e-05	0.000361	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—ENO2—bone cancer	1.62e-05	0.000347	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—GNA11—bone cancer	1.58e-05	0.000337	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—DHFR—bone cancer	1.51e-05	0.000322	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—ENO2—bone cancer	1.48e-05	0.000317	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—GSTP1—bone cancer	1.44e-05	0.000309	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—CYP3A4—bone cancer	1.43e-05	0.000306	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.42e-05	0.000304	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—GNA11—bone cancer	1.41e-05	0.000301	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—DHFR—bone cancer	1.37e-05	0.000294	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—GNA11—bone cancer	1.28e-05	0.000275	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—CYP3A4—bone cancer	1.28e-05	0.000273	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.27e-05	0.000272	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—GSTP1—bone cancer	1.22e-05	0.000262	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—CYP3A4—bone cancer	1.16e-05	0.000249	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.16e-05	0.000248	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—GSTP1—bone cancer	1.09e-05	0.000234	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—GSTP1—bone cancer	9.95e-06	0.000213	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—ENO2—bone cancer	9.76e-06	0.000209	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—DHFR—bone cancer	9.05e-06	0.000194	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—GNA11—bone cancer	8.46e-06	0.000181	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—PTGS2—bone cancer	7.48e-06	0.00016	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—GSTP1—bone cancer	6.56e-06	0.00014	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—PTGS2—bone cancer	6.33e-06	0.000136	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—PTGS2—bone cancer	5.65e-06	0.000121	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—PTGS2—bone cancer	5.15e-06	0.00011	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—PTGS2—bone cancer	3.4e-06	7.28e-05	CbGpPWpGaD
